January 12 (SeeNews) - The European Investment Bank (EIB) said on Friday it signed a 100 million euro ($121.3 million) loan deal with Bulgarian agri-pharma company Huvepharma to finance a capacity expansion project of its majority-owned subsidiary Biovet.